Jacobio Pharma(HKEX: 1167) today announced its annual results for the year ended Dec. 31, 2025, and provided updates on its key pipeline programs. During 2025, the company achieved several key ...

Using single-cell sequencing, researchers found distinct immune profiles in different CNS tumors, highlighting its potential as a prognostic tool.

Virus-associated cancers are a significant and persistent global health challenge, providing unique insight into the relationship between chronic infection ...